Johnson Financial Group, LLC Merck & Co., Inc. Transaction History

Johnson Financial Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $202,797 - $229,880	2,429 New	2,429 $221,000
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $390,999 - $438,285	-5,319 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $2,168 - $2,716	-30 Reduced 0.56%	5,319 $408,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $113,254 - $124,551	-1,580 Reduced 22.8%	5,349 $401,000
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $172,189 - $190,458	2,449 Added 54.67%	6,929 $539,000
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $308,492 - $363,372	4,480 New	4,480 $345,000
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $354,448 - $411,332	-5,433 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $51,214 - $59,526	1,005 Added 22.7%	5,433 $295,000
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $50,587 - $60,407	-980 Reduced 18.12%	4,428 $249,000
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $23,820 - $25,630	406 Added 8.12%	5,408 $346,000
Q2 2017 Nov 03, 2017	BUY	N/A	5,002	5,002 $320,000

3,815

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Johnson Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Johnson Financial Group, LLC with notifications on news.